Flexion Therapeutics
FLXN
#7310
Rank
โ‚ฌ0.39 B
Marketcap
7,83ย โ‚ฌ
Share price
0.00%
Change (1 day)
7,423.73%
Change (1 year)

Revenue for Flexion Therapeutics (FLXN)

Revenue in 2021 (TTM): โ‚ฌ84.54 Million

According to Flexion Therapeutics 's latest financial reports the company's current revenue is โ‚ฌ86.23 Million. In 2020 the company made a revenue of โ‚ฌ73.48 Million an increase over the revenue in the year 2019 that were of โ‚ฌ62.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Flexion Therapeutics from 2018 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ84.54 M15.05%
2020โ‚ฌ73.48 M17.26%
2019โ‚ฌ62.66 M223.91%
2018โ‚ฌ19.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cara Therapeutics
CARA
โ‚ฌ6.12 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ64.72 M-24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 91,681.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 62,435.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚ฌ0.55 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚ฌ0.61 B 613.94%๐Ÿ‡บ๐Ÿ‡ธ USA